Directory
>
Sugato De
Sugato De
Vice President, Regulatory Strategy - Head of MedTech and Clinical Strategy | Pharm-Olam, LLC
Bethesda, Maryland, United States
Sugato De
Summary
Sugato De is a highly experienced regulatory professional with a robust background in biomedical engineering, specializing in the medical devices and combination products sector. Currently serving as the Vice President of Regulatory Strategy at Allucent, he leads strategic initiatives for medical technology and provides expert guidance for clients navigating regulatory pathways. Sugato's extensive experience at the FDA has equipped him with deep insights into regulatory policies and procedures. With a strong academic foundation from prestigious institutions like Johns Hopkins University and Rensselaer Polytechnic Institute, he holds advanced degrees in biomedical engineering. His professional interests include precision medicine and digital health technology, reflecting his commitment to innovation in healthcare. Sugato is passionate about mentoring the next generation of regulatory professionals and actively contributes to discussions on emerging technologies in the medical field.
Sugato De
Work Experience
Vice President, Regulatory Strategy - Head of MedTech and Clinical Strategy at
Pharm-Olam, LLC
December 2022 - Present
Vice President - Technical at
Parexel
November 2018 - January 2023
Principal Consultant at
Parexel
October 2016 - January 2023
Senior Policy Advisor, Office of the Center Director at
FDA
May 2013 - October 2016
Biomedical Engineer at
FDA
October 2007 - May 2013
Project Associate at
Stryker
January 2007 - September 2007
Sugato De
Education
Johns Hopkins University, Master's Degree
January 2008 - January 2010
Rensselaer Polytechnic Institute, Bachelor's Degree
January 2003 - January 2007
Frequently Asked Questions about Sugato De
What is Sugato De email address?
Sugato De's primary email address is ******@allucent.io. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Sugato De work for?
Sugato De is a Vice President, Regulatory Strategy - Head of MedTech and Clinical Strategy at Pharm-Olam, LLC, a company specializing in Pharmaceutical & Medicine Manufacturing.
Where Sugato De graduated from?
Sugato De holds a degree in Biomedical/Medical Engineering from Johns Hopkins University.
How can I directly contact Sugato De?
To contact Sugato De directly, you can use the email address ******@allucent.io. Complete contact information is available upon registration with Muraena.
Who is Sugato De?
Sugato De is a highly experienced regulatory professional with a robust background in biomedical engineering, specializing in the medical devices and combination products sector. Currently serving as the Vice President of Regulatory Strategy at Allucent, he leads strategic initiatives for medical technology and provides expert guidance for clients navigating regulatory pathways. Sugato's extensive experience at the FDA has equipped him with deep insights into regulatory policies and procedures. With a strong academic foundation from prestigious institutions like Johns Hopkins University and Rensselaer Polytechnic Institute, he holds advanced degrees in biomedical engineering. His professional interests include precision medicine and digital health technology, reflecting his commitment to innovation in healthcare. Sugato is passionate about mentoring the next generation of regulatory professionals and actively contributes to discussions on emerging technologies in the medical field.
Sugato`s contact details
******@allucent.io
*********@parexel.com
*********@fda.gov
*********@allucent.com
Colleagues
Vice President, Information Technology and Security
VP, Global Head Regulatory and Drug Development Consulting
Vice President, Biostatistics and Statistical Programming
Vice President Regulatory Strategy
Chief Medical Officer
Vice President Of Quality
Vice President Global Proposals and Business Operations
Vice President Shared Services
President, Clinical Pharmacology Modeling and Simulation
Chief Operating Officer & General Counsel